Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk prediction of hepatocellular carcinoma in patients with cirrhosis: The ADRESS-HCC risk model

Published:2014-07-16 Issue:22 Volume:120 Page:3485-3493
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Flemming Jennifer A.¹,Yang Ju Dong²,Vittinghoff Eric³,Kim W. Ray⁴,Terrault Norah A.⁵

Affiliation:

1. Division of Cancer Care and Epidemiology, Department of Medicine; Queen's University; Kingston Ontario Canada

2. Department of Internal Medicine; University of Arkansas for Medical Science; Little Rock Arkansas

3. Department of Epidemiology and Biostatistics; University of California at San Francisco; San Francisco California

4. Division of Gastroenterology and Hepatology, Stanford University; Stanford California

5. Department of Medicine; University of California at San Francisco; San Francisco California

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28832/fullpdf

Reference28 articles.

1. Rising incidence of hepatocellular carcinoma in the United States;El-Serag;N Engl J Med,1999

2. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005;Altekruse;J Clin Oncol,2009

3. cdc.gov/Nchs/

4. Hepatocellular carcinoma in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tobacco is a Leading Risk Factor for Liver and Extrahepatic Cancers in Patients With Liver Cirrhosis: A Prospective Cohort Study;Journal of Clinical and Experimental Hepatology;2024-11

2. Porto-sinusoidal Vascular Disease and Portal Hypertension;Clinics in Liver Disease;2024-08

3. Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease;JAMA Network Open;2024-07-11

4. LIRIC predicts Hepatocellular Carcinoma risk in the diverse U.S. population using routine clinical data;2024-05-29

5. Role of biomarkers in the diagnosis and management of HCC;Liver Transplantation;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3